Attorneys representing about 300 lawsuits alleging that Risperdal causes enlargement of breast tissue in men have asked a Pennsylvania judge to unseal relevant clinical studies data. Johnson & Johnson had previously argued that there was no reason to unseal the documents as they were generated for researchers and regulators and not for the general public.
Of further interest:
Documents and Resources from the November 4, 2013 Johnson & Johnson Press Conference (United States Department of Justice)
